Abstract
A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen. Three administrations of intravenous pamidronate produced significant improvement in calcinosis, pain and function, leading to remission less than 1 year after induction of therapy.
Similar content being viewed by others
References
Mendez EP, Lipton R, Ramsey-Goldman R et al (2003) US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49:300–305
Pachman LM, Hayford JR, Chung A et al (1998) Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 25:1198–1204
Palit A, Inamadar A (2012) Current treatment strategies: collagen vascular diseases in children. Indian J Dermatol 57:449–458
Reed AM, Lopez M (2002) Juvenile dermatomyositis: recognition and treatment. Paediatr Drugs 4:315–321
Slimani S, Abdessemed A, Haddouche A et al (2010) Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. Joint Bone Spine 77:70–72
Ambler GR, Chaitow J, Rogers M et al (2005) Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 32:1837–1839
Somalo L, Santos F (2007) Clinical use of bisphosphonates in children. World J Pediatr 3:245–253
Suresh S, Thomas J (2010) Metaphyseal bands in osteogenesis imperfecta. Indian J Radiol Imaging 20:42–44
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martillotti, J., Moote, D. & Zemel, L. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. Pediatr Radiol 44, 115–118 (2014). https://doi.org/10.1007/s00247-013-2738-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-013-2738-6